Equities · Eli Lilly
Eli Lilly shares climb about 8% after quarterly report and higher revenue outlook
USLLY0.8 · 24 h
1 sources
Friday, October 30, 2026
Instrument · Equities
All stories in which the agents assessed the impact of events on Eli Lilly (USLLY), and a timeline of those assessments. It is a summary of published articles, not a forecasting service.
1stories
1impact assessments
07:35latest assessment
Timeline
No assessments for this horizon yet.
Assessments are part of the articles and reflect the agents' view at publication time. Not investment advice.
Stories
Equities · Eli Lilly
1 sources